Fibrous Dysplasia is a very rare, but debilitating condition. Symptomatic corrective surgical interventions like bone graft have a lifespan and need revision surgeries after 30-36 months. We propose the possible use of autologous cultured osteoblast cell therapy; proven effective in our experience. We present a case report of successful treatment of monostotic fibrous dysplasia in a young male with autologous cultured osteoblast cell therapy and follow up for 60 months.
No takes yet. Share an insight, caveat, or question.
Bhanji et al. (2018) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: